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ABSTRACT  
Quercetin, a bioflavonol is widely found in nature and 
possesses diverse pharmacological properties. A heterocyclic 1,4 
dioxane nucleus was incorporated in Quercetin structure to obtain 
two structural analogues of silybin. The aim of the study was to 
antihepatotoxic potential of Quercetin derivatives containing 1,4 
dioxane heterocyclic ring in Carbon tetrachloride (CCl4) induced 
hepatotoxicity in female Wistar Albino rats. Two Quercetin 
derivatives (QD) were synthesized by reported method. QD were 
administered orally at dose of 10 mg/kg, once daily for 7 days to 
Wistar Albino rats. A single dose of CCl4 (1mL/kg) was used for 
inducing liver damage. Antihepatotoxic activity was evaluated by 
measuring levels of  total proteins (TP), total albumin (TA), alkaline 
phosphatase (ALKP) and  liver enzymes such as serum glutamate 
oxaloacetate (SGOT) and serum glutamate pyruvate transaminase 
(SGPT).QD exhibited potent antihepatotoxic activity with respect to 
standard drug silybon-70. However, it was observed that the 
Quercetin derivative having –CH2OH group in the dioxane ring 
exhibited  better activity in comparision to unsubstituted 1,4 
dixoane ring derivative.The exact mechanism by which QD protects 
the liver is unknown however the observed effects could be 
attributed to presence of 1,4 dioxane ring  and  due to the 
significant antioxidant activity of Quercetin flavone. 
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INTRODUCTION 
Liver is an important organ regulating 
homeostasis in the body. It is involved in the 
detoxification and excretion of various 
endogenous and exogenous substances. It 
protects against the harmful effects of drugs 
and chemicals and thus frequently exposed to 
variety of toxicants resulting in liver diseases 
(Meyer and Kulkarni, 2001).  Liver disease, a 
leading cause of death in many countries, is a 
major concern throughout the world. The 
different medical, surgical and therapeutic 
methods available at present for the treatment 
of liver diseases are inadequate with generally 
poor results (Davies, 1985). Therefore, it is 
essential to search for newer drugs for the 
treatment of liver diseases. 
It is well known that some naturally 
occuring medicinal plants are potent 
hepatoprotective drugs  and are  widely used  in  
alternative system of medicine through out the 
world to treat liver ailments (Handa et al., 1986). 
Silymarin isolated from the seeds of Silybum 
marianum commonly known as milk thistle, is 
used as a potent antihepatotoxic agent against 
variety of toxicants in modern medicine 
(Morazzoni and  Bombardelli, 1995). It is a 
complex mixture of three flavolignan isomers 
namely, silybin, silydianin and silychristin (Flora 
et al., 1998) (Figure 1). Silybin contains 1,4 
dioxane ring system in its structure and is the 
most active component, whereas Silychristin 
and Silydianin do not possess 1, 4 –dioxane 
ring, and thus do not display significant activity 
(Ahmed et al., 2003). We, therefore, proposed 
that 1, 4 dioxane unit plays an important role in 
exhibiting antihepatotoxic activity and thus 
evaluated the antihepatotoxic potential of many 
natural and synthetic products after 
incorporating 1,4  dioxane ring system  in  their  
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skeleton in search of effective and safer 
antihepatotoxic agents (Ahmed et al., 2003; 
Khan et al., 2006).  
Quercetin (2-(3,4-dihydroxyphenyl)-3,5,7 
-trihydroxy-4H-chromen-4-one), a polyhydroxy 
flavone is found in many herbal drugs and 
foods and demonstrates diverse biopharma-
cological properties (Boots et al., 2008)  
Quercetin prevents the oxidation of low-
density lipoproteins (LDL) by scavenging free 
radicals and chelating transition metal ions and 
helps in the prevention of certain diseases, such 
as cancer, atherosclerosis, and chronic inflam-
mation etc (Hollman and Katan, 1997; Muraota 
and Terao, 2003). 1,4 dioxane ring was 
incorporated into the Quercetin structure by 
condensing 3,4 dihydroxy phenyl group of 
Quercetin with ethylene bromide or 
epicholorohydrin as per reported method to 
yield two new Quercetin derivatives (Figure 2) 
(Ahmed et al., 2003). The QD (2a and 2b) 
possessing H and CH2OH group at 2nd  
position of benzodioxane ring were evaluated 
for anticipated antihepatotoxic activity in 
carbon tetrachloride induced hepatotoxicity in 
rodents.  
 
METHODOLOGY 
Experimental animals 
 The antihepatotoxic studies of 
compounds (2a and 2b) were carried out on the 
female Wistar albino rats (150-200 g). The 
study was approved by an institutional animal 
ethics committee and ethical norms were 
strictly followed during all the experimental 
procedures. The rats were bred in a colony in 
the Central Animal House of Jamia Hamdard. 
They were fed with a standard pellet diet (Gold 
Mohar, Lipton India Ltd., Calcutta) and water 
ad libitum. Before and during the experiment, 
the rats were kept in a standard environmental 
conditions (temp. 25-28° C and 12 h light/dark 
cycle).  
 
Treatment schedule 
 Animals were divided into five groups 
of five animals each in all the sets of 
experiments. CCl4 mixed with liquid paraffin 
(1:1) was used as hepatotoxic agent. The drugs 
were administered for seven days after CCl4 
administration, in the form of an aqueous 
suspension made from carboxymethyl cellulose 
as per the following treatment schedule;  
 
 
Figure 1. Chemical structures of silybin, (1a), silydianin (1b) 
and silychrystin (1c) 
 
 
 
Figure 2. Chemical structures of quercetin derivatives 
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Group I (Normal control) was given 
only distilled water for 7 days; Group II (Toxic 
control) was treated with CCl4 (1.0 mL/kg) for 
the first day of study to produce toxicity in the 
liver;  Group III (silybon-70 treated) was given 
a single dose of CCl4 (1.0 mL/kg) on the first 
day and then silybon-70, 10 mg/kg, daily) was 
given for seven days; Groups IV and V were 
administered with a single dose of CCl4 (1.0 
mL/kg) on the first day followed by an oral 
treatment with a daily dose (10 mg/kg) of 
dioxino quercetin 2a and 2b respectively for 
seven days.  
On the last day, blood was collected 
directly from the retro plexus orbital of four 
rats from each group and serum was separated 
for biochemical analysis.  
 
Biochemical analysis 
 The biochemical parameters such as 
SGOT (Rietman and Frankel, 1957), SGPT 
(Kind and King, 1954) , ALKP (Wooton, 1964) 
, TP and TA were analyzed according to the 
reported methods (Khan and Ahmed, 2011).  
 
Statistical analysis 
 The results of the biochemical 
estimations are reported as mean  S.E.M. 
Statistical analysis was done by one-way analysis 
of variance (ANOVA) followed by Student’s        
't' test by using 13th version of SPSS software.  
P values <0.05 were considered as significant. 
 
RESULTS AND DISCUSSION 
The effect of QD on serum biomarker 
enzymes is presented in table no 1. The levels 
of SGOT, SGPT, ALKP, TA were markedly 
elevated, and that of TP decreased after a single 
dose of CCl4 (1 mL/kg) in toxic control group 
as compared to the normal animals, indicating 
hepatocellular damage. The activities of the bio 
marker enzymes for liver such as SGOT, 
SGPT, AKLP and TA were elevated on 
administration of CCl4 to 71.52, 59.4, 46.34 
units/mL and 4.30 g/dL respectively in 
comparison to normal values of 36.28, 30.30, 
15.8 units/mL and 3.32g/dL respectively. 
Treatment of the rats with Silybon-70, a 
standardized extract of silymarin and two 
synthesized QD at dose levels of 10 mg/kg 
body weight, prevented CCl4-induced elevation 
of SGOT, SGPT, ALKP, TA and also 
prevented decrease in TP. Both  QD prevented 
the CCl4 induced hepatotoxicity as they 
decreased the levels of SGOT (55.84 and 53.7 
units/mL), SGPT (46.82 and 46.28  units/mL),  
ALKP (37.8  and 32.6 units/mL), TA (3.57 and 
3.63 g/dL) and increased the level of TP (5.43 
and 5.66 g/dL), which were found to be 
comparable to the effect produced by standard 
drug Silybon-70 (53.84, 45.8 and 28.88 
units/mL for SGOT, SGPT and ALKP 
respectively, 6.29 and 3.26 g/dL for TP and TA 
respectively).  
CCl4 is one of the most commonly used 
hepatotoxins in experimental studies of liver 
diseases (Johnson and Kroening, 1998). The 
hepatotoxic effects of CCl4 are largely due to its 
active metabolite, trichloro methyl (CCl3) 
radical (Srivastava et al., 1990) that disrupts the 
structure and function of lipid and protein 
macromolecules in the membrane of the cell 
organelles. The elevated levels of serum bio 
marker enzymes are indicative of cellular 
leakage and loss of functional integrity of the 
cell membrane due to toxicity produced by 
CCl4. Significant rise in serum enzymatic 
concentration viz. SGOT and SGPT could be 
taken as an index of liver damage. 
Silymarin, the active ingredient of 
Silybon-70, is a well established hepato-
protective drug capable of decreasing the 
elevated levels of liver enzymes in various drug 
induced hepatotoxicity through multiple 
actions. The antioxidant property and cell-
regenerating functions as a result of increased 
protein synthesis are considered as the most 
important (Kosina et al., 2002). QD are 
structural analogs of silybin, so expected to 
protect against CCl4 induced hepatotoxicity by 
the similar antioxidant mechanism. In addition 
to structural resemblance, QD are of low 
molecular weight and thus can be easily 
metabolized in vivo as compared to complex 
isomeric mixture of silymarin. 
The QD with hydroxyl methyl group at 
2nd position on the 1,4 dioxane ring (2b) 
showed better antihepatotoxic activity than the 
quercetin derivative  with unsubstituted 1,4 
dioxane ring (2a). Compound 2b significantly 
reversed the hepatotoxicity and exhibited 
almost  similar  activity  comparable to standard 
drug  silybon- 70 by  bringing  back the enzyme 
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levels to near normal. This could be due to the 
fact that compound 2b resembles structurally 
and chemically to silybin, the most active 
isomer of silymarin. Both are poly hydroxyl 
flavones possessing the –CH2OH group at the 
same position on the dioxane ring. The 
outcome of this study is in accordance with the 
previously reported results from our lab 
(Ahmed et al., 2003; Khan et al., 2006; Khan 
and Ahmed, 2011).  
 
CONCLUSION 
In the present study, administration of 
QD containing 1,4 dioxane ring system 
significantly protected against CCl4 induced 
hepatotoxiciy in rats. Compound 2b having a 
hydroxymethyl group on the 1,4 dioxane ring 
was found to be more potent  than compound 
2a with unsubstituted 1,4 dioxane ring. The 
exact mechanism by which it protects the liver 
is unknown however the effect could be due to 
the significant antioxidant activity of Quercetin 
(Harborne, 1999) and due to the presence of 
1,4 dioxane ring. Further detailed studies are 
needed to probe their role as antihepatotoxic 
agent and to ascertain the exact mechanism of 
action. 
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